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ABSTRACT
Exosomes are membraneous nanovesicles of
endocytic origin released by most cell types from
diverse organisms; they play a critical role in
cell–cell communication. ExoCarta (http://www
.exocarta.org) is a manually curated database of
exosomal proteins, RNA and lipids. The database
catalogs information from both published and
unpublished exosomal studies. The mode of
exosomal purification and characterization, the
biophysical and molecular properties are listed in
the database aiding biomedical scientists in assess-
ing the quality of the exosomal preparation and the
corresponding data obtained. Currently, ExoCarta
(Version 3.1) contains information on 11261 protein
entries, 2375 mRNA entries and 764 miRNA entries
that were obtained from 134 exosomal studies.
In addition to the data update, as a new feature,
lipids identified in exosomes are added to
ExoCarta. We believe that this free web-based com-
munity resource will aid researchers in identifying
molecular signatures (proteins/RNA/lipids) that
are specific to certain tissue/cell type derived
exosomes and trigger new exosomal studies.
INTRODUCTION
Exosomes are 40–100nm diameter membrane vesicles
of endocytic origin that are released by most cell types
under normal and pathological conditions upon fusion
of multivesicular bodies (MVBs) with the plasma
membrane (PM) (1,2). Since the original observation of
exosome secretion from reticulocytes (3,4), the release of
these membrane particles in vitro into culture medium
is reported in other cells (2,5–7). Exosomes have a cup
shaped appearance as visioned by electron microscopy,
a buoyant density in sucrose of 1.10–1.21g/ml; and
sediment at 100000g. Exosomes harbor proteins/RNA/
lipids that reﬂect the functionality of the host cell and
posses molecular signatures or footprints resembling the
diseased cell from which they were secreted (7). Recent
studies have shown that exosomes can be isolated in vivo
in bodily ﬂuids such as blood (8), urine (9), breast milk
(10), amniotic ﬂuid (11), malignant ascites (12),
bronchoalveolar lavage ﬂuid (13) and synovial ﬂuid (14).
The accessibility of exosomes in bodily ﬂuids makes them
an ideal specimen for biomarker discovery.
While several protocols are employed to isolate and
purify exosomes, characterizing them is strongly based
on electron microscopy (size and shape) and western
blotting for the existence of protein markers that are
involved in exosomal biogenesis such as PDCD6IP
(Alix), TSG101 and/or exosomal membrane molecules
such as CD9, CD63 and CD81. As the number of
exosomal studies expands to include more organisms
and cell types, new insights are gained on proteins
common to all exosomes irrespective of the cell-type
origin as well as host–cell-speciﬁc proteins (15). A
database of proteins, RNA and lipids identiﬁed in
exosomes will reveal classes of molecules that are more
often found in exosomes and those that are speciﬁc to
certain cell types. Such additional information on host
cell speciﬁc exosomal membrane molecules will trigger
further immunoafﬁnity-based studies and aid biomedical
researchers to isolate disease cell derived exosomes devoid
of exosomes secreted by other normal cells. Here we
describe, ExoCarta, a manually curated web-based
database (http://www.exocarta.org) of the exosomal mo-
lecular components such as lipids, proteins, mRNA and
miRNA as reported in the scientiﬁc literature (16). More
importantly, the database contains annotations on the
exosomal isolation and puriﬁcation procedures which
will indicate the users on the reliability of the exosome
preparation.
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FUNCTIONALITY
ExoCarta was previously described 2 years ago (16).
Brieﬂy, ExoCarta is built with ZOPE, an open source
Python-based web application server with dynamic
HTML templates, scripts, a search engine and connections
for a relational database. Python is used in the three-tier
system to connect the web interface with a MySQL
database. ExoCarta can be queried using the gene
symbol/name or browsed as a set based on the organism,
content type (proteins or lipids) and the sample material
(plasma or urine). The molecule page in ExoCarta
provides the users with molecule centric view on experi-
ment description of the study that identiﬁed the molecule,
isolation procedures employed, gene ontology-based an-
notations, protein–protein interactions and a graphical
display of the interaction network. Meta annotations re-
garding the experiment description include the sample
from which exosomes were isolated (e.g. plasma, breast
cancer cell line), isolation procedures, the identiﬁcation
method (e.g. mass spectrometry), PubMed identiﬁers, in-
vestigators of the study, the journal in which the article
was published, the year of the publication. Protein–
protein interaction data that was obtained from
BioGRID (17) is used in the molecule page to display
the protein interaction network graphically as nodes and
edges (Figure 1).
ExoCarta DATABASE ADDITIONS AND
NEW FEATURES
Data update
Since the introduction of ExoCarta in April 2009 (16),
the exosomal studies added to ExoCarta have doubled.
As shown in Table 1, ExoCarta currently comprises
11261 protein entries resulting from 4049 unique
proteins. A total of 4049 mRNA entries and 764
miRNA entries obtained from 134 independent studies
are also cataloged in ExoCarta. As homogenous popu-
lation of exosomes is of paramount importance, the
isolation procedures used will indicate the users on
the reliability of the exosome preparation and the corres-
ponding data obtained. In this regard, every study in
ExoCarta is annotated carefully for the experimental pro-
cedures employed to isolate exosomes. Typical isolation
procedures such as differential centrifugation, size-based
membrane ﬁltration, rate zonal centrifugation, ﬂow
cytometry and immunoafﬁnity pull downs are clearly
indicated along with the ﬂoatation gradient density of
exosomes as reported in the study. The statistical distribu-
tion of the isolation protocols used in the studies
catalogued in ExoCarta is displayed in Figure 2. Totally,
84% of the studies employed differential centrifugation,
56% used rate zonal centrifugation, 30% used ultracen-
trifugation and 9% employed immunoafﬁnity-based
Figure 1. A snapshot of the protein molecule page of TSG101 in ExoCarta is displayed. Users can access molecule centric information from the
protein molecule page in ExoCarta. The gene ontology annotations, protein–protein interaction network, graphical display of the network, experi-
mental description pertaining to the studies that identiﬁed TSG101, mass spectrometry-based peptide identiﬁcations along with the MS/MS spectra
and autoradiographs for western blotting are provided wherever possible as supporting information.
D1242 Nucleic AcidsResearch, 2012,Vol. 40,Database issuemethods. It has to be noted that many of the studies used
a combination of these procedures. For example, ﬁltration
(26%), cannot be used alone to isolate exosomes, was used
in conjunction with other isolation procedures. While
earlier exosomal studies employed the far simpler
approaches of differential centrifugation (15,18), it is
encouraging to see that recent exosomal studies are
using stringent protocols to isolate exosomes to homogen-
eity. This is evident by the fact that only 17 of the
134 studies used differential centrifugation alone as the
isolation procedure.
Addition of lipids
As a new feature of ExoCarta, lipid molecules identiﬁed in
various exosomal studies are also added in the database.
Recent studies on exploring the function/composition
of lipids in exosomes have resulted in handful of lipid-
based exosomal studies. Currently, ExoCarta catalogs
10 lipid-based exosomal studies. Lipid composition
analysis have been performed with exosomes derived
from dendritic cells (19), basophilic leukemia cells (20),
mast cells (19), reticulocytes (21) and B cells (22). Lipids
play a vital role in exosome biogenesis (23) and are char-
acteristic of the cell origin. Interestingly, internal mem-
branes of MVBs are shown to be enriched with lipids
such as lyosbisphosphatidic acid (LBPA) (24) which
plays an important role in exosome biogenesis, especially
ILV formation (23).
Involvement of exosomal community
Manual curation of scientiﬁc literature is a cumbersome
process. Most of the data present in the scientiﬁc literature
either as inline text or in the supplementary tables
cannot be easily queried upon and are generally lost
over time (25). Already existing exosomal datasets in the
scientiﬁc literature either as inline text or in the supple-
mentary tables are annotated in a communal repository
(ExoCarta) with the aid of manual curation. However, in
order to keep the database updated, it is very important
for the involvement of the exosome scientiﬁc community.
To facilitate the active involvement of the exosomal scien-
tiﬁc community, we have incorporated data contributions
with undue credit provided to investigators who generated
the data. In this regard, we have instituted a mechanism
that allows referees to access exosomal data sets that are
submitted by authors before publication in an authorized
and anonymous fashion for evaluation purposes.
The uploaded data will be highlighted as private and can
only be accessed by the authors or their collaborators.
Alternatively, the authors can make the data publicly
accessible whenever they are inclined to do so. By
undertaking such ways of data deposition, the onus on
the curators can be reduced several folds. All contributing
Figure 2. Distribution of exosomes isolation procedures in the studies catalogued in ExoCarta. A histogram of the distribution of exosome isolation
procedures in exosomal studies is displayed. As shown, 84% of the studies employed differential centrifugation, 56% used rate zonal centrifugation
and 9% employed immunoafﬁnity-based methods. It has to be noted that many of the studies used a combination of these procedures. For example,
ﬁltration (26%), cannot be used alone to isolate exosomes, was used in conjunction with other isolation procedures.
Table 1. Statistics of data cataloged in ExoCarta
1 Number of exosome studies 134
2 Number of protein entries 11261
3 Number of proteins 4049
4 Number of mRNA entries 2375
5 Number of mRNA molecules 1639
6 Number of lipid molecules 58
7 Number of miRNA molecules 764
8 Number of organisms from which exosomes were isolated 8
9 Number of cell types from which exosomes were isolated 93
10 Number of body ﬂuids from which exosomes were isolated 12
Nucleic Acids Research, 2012,Vol. 40,Database issue D1243investigators and the datasets will be listed in ExoCarta
credits page (http://www.exocarta.org/credits). Currently,
eight investigators have provided their exosomal datasets
to the database and we expect more contributions from
the exosomal community in the near future.
FUTURE DIRECTIONS
ExoCarta will be updated with more exosomal studies
and more ﬁelds including protein–protein interactions
and post-translational modiﬁcations will be incorporated.
Microvesicle-based datasets will also be added to
ExoCarta in the near future but with clear annotations
representing the type/name of the vesicle. ExoCarta will
also function as an active news forum in terms of high-
lighting international scientiﬁc meetings and workshops in
the context of exosomes or microvesicles. We intend to
involve the exosomal scientiﬁc community in updating
ExoCarta and foresee ExoCarta as a primary resource
for exosome research.
DATA USABILITY
ExoCarta is a free to use web-based database. The
manually curated data present in ExoCarta (Version 3.1)
is available as tab-delimited ﬁles and is free for download
to all the users.
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